Advanced search

Find pages with...
Then narrow your results by...

About 1 search results

Archived – Important New Safety Information Clarifying Risk Factors for Severe, Life-threatening and Fatal Hepatotoxicity with VIRAMUNE® (Nevirapine)

http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2004/14293a-eng.php

Jun 4, 2013 ... information being added to the Warnings Section of the Product Monograph for VIRAMUNE Tablets, 200 mg, a non-nucleoside reverse transcriptase inhibitor indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents. Specifically, we wish to draw your attention to the following: Women with CD4+ counts >250 cells/mm3 at initiation

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: